[HTML][HTML] The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape

D Zipinotti dos Santos, JC de Souza… - Cell Communication and …, 2023 - Springer
Background Breast cancer (BC) is the second most frequent type of cancer in the world and
most common among women, configuring a major challenge to global health. BC is a …

[HTML][HTML] Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer

C Xue, Q Yao, X Gu, Q Shi, X Yuan, Q Chu… - Signal transduction and …, 2023 - nature.com
The Janus kinase (JAK) signal transducer and activator of transcription (JAK-STAT) pathway
is an evolutionarily conserved mechanism of transmembrane signal transduction that …

Combining TIGIT blockade with MDSC inhibition hinders breast cancer bone metastasis by activating antitumor immunity

L Monteran, N Ershaid, Y Scharff, Y Zoabi… - Cancer …, 2024 - aacrjournals.org
Bone is the most common site of breast cancer metastasis. Bone metastasis is incurable and
is associated with severe morbidity. Utilizing an immunocompetent mouse model of …

[HTML][HTML] Unraveling the role of hepatic PGC1α in breast cancer invasion: a new target for therapeutic intervention?

K Ganesan, C Xu, Q Liu, Y Sui, J Chen - Cells, 2023 - mdpi.com
Breast cancer (BC) is the most common cancer among women worldwide and the main
cause of cancer deaths in women. Metabolic components are key risk factors for the …

Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial

H Mo, Y Yu, X Sun, H Ge, L Yu, X Guan, J Zhai, A Zhu… - Nature Medicine, 2024 - nature.com
It remains unclear whether metronomic chemotherapy is superior to conventional
chemotherapy when combined with immune checkpoint blockade. Here we performed a …

[HTML][HTML] High numbers of CD163+ tumor-associated macrophages predict poor prognosis in HER2+ breast cancer

MM Jääskeläinen, R Tumelius, K Hämäläinen, K Rilla… - Cancers, 2024 - mdpi.com
Simple Summary While tumor-associated macrophages (TAMs) are known to be associated
with a poor prognosis in breast cancer (BC) in general, how they influence different BC …

[HTML][HTML] Insights into the role of derailed endocytic trafficking pathway in cancer: From the perspective of cancer hallmarks

H Guo, C Zhou, M Zheng, J Zhang, H Wu, Q He… - Pharmacological …, 2024 - Elsevier
The endocytic trafficking pathway is a highly organized cellular program responsible for the
regulation of membrane components and uptake of extracellular substances. Molecules …

Type‐I protein arginine methyltransferase inhibition primes anti‐programmed cell death protein 1 immunotherapy in triple‐negative breast cancer

S Zhang, L Guo, Z Zhang, X Liu, W Chen, Y Wei… - Cancer, 2024 - Wiley Online Library
Background Immune‐checkpoint blockade (ICB) therapy shows promise for treating
aggressive triple‐negative breast cancer (TNBC). However, only some patients benefit from …

Betulinic acid in the treatment of breast cancer: Application and mechanism progress

H Mu, Y Sun, B Yuan, Y Wang - Fitoterapia, 2023 - Elsevier
Betulinic acid (BA) is a pentacyclic triterpene compound, which can be obtained by
separation, chemical synthesis and biotransformation. BA has excellent biological activities …

[HTML][HTML] Tailoring therapies to counter the divergent immune landscapes of breast cancer

S Attalla, T Taifour, W Muller - Frontiers in Cell and Developmental …, 2023 - frontiersin.org
Breast cancer remains a significant clinical concern affecting millions of women worldwide.
Immunotherapy is a rapidly growing drug class that has revolutionized cancer treatment but …